Warfarin-induced hypoprothrombinemia. Potentiation by hyperthyroidism.

Suppr

超能文献

作者信息

Self T, Weisburst M, Wooten E, Straughn A, Oliver J

出版信息

JAMA. 1975 Mar 17;231(11):1165-6.

PMID:1172818

Abstract

摘要

相似文献

Warfarin-induced hypoprothrombinemia. Potentiation by hyperthyroidism.

JAMA. 1975 Mar 17;231(11):1165-6.

Enhancement of warfarin-induced hypoprothrombinemia by thyrotoxicosis.

Johns Hopkins Med J. 1972 Jul;131(1):69-73.

[Therapeutic effect of menaquinone-4 (K2) on hypoprothrombinemia caused by warfarin].

Nihon Yakurigaku Zasshi. 1971 Jul;67(4):412-8.

Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate.

N Engl J Med. 1970 Oct 15;283(16):827-31. doi: 10.1056/NEJM197010152831601.

Prothrombin complex concentrates in acquired hypoprothrombinemia.

Ann Intern Med. 1973 Oct;79(4):485-91. doi: 10.7326/0003-4819-79-4-485.

Interaction between warfarin and ethacrynic acid.

JAMA. 1975 Feb 24;231(8):843-4.

Enhancement of warfarin-induced hypoprothrombinemia by triclofos.

Clin Pharmacol Ther. 1972 Nov-Dec;13(6):911-5. doi: 10.1002/cpt1972136911.

The interaction of lovastatin and warfarin.

Conn Med. 1992 Feb;56(2):107.

Effect of dicloxacillin sodium on the hypoprothrombinemic response to warfarin sodium.

Clin Pharm. 1987 Oct;6(10):804-6.

HYPOPROTHROMBINEMIA AS A COMPLICATION OF PROPYLTHIOURACIL.

JAMA. 1964 Sep 14;189:855. doi: 10.1001/jama.1964.03070110057020.

引用本文的文献

COVID-19 associated thyroid dysfunction and other comorbidities and its management using phytochemical-based therapeutics: a natural way.

Biosci Rep. 2023 Jul 26;43(7). doi: 10.1042/BSR20230293.

Hemostasis in Overt and Subclinical Hyperthyroidism.

Int J Endocrinol Metab. 2017 Apr 23;15(3):e44157. doi: 10.5812/ijem.44157. eCollection 2017 Jul.

Bleeding heart: a case of spontaneous hemopericardium and tamponade in a hyperthyroid patient on warfarin.

BMJ Case Rep. 2016 Jul 13;2016:bcr2016215731. doi: 10.1136/bcr-2016-215731.

Extremely elevated international normalized ratio of warfarin in a patient with CYP2C9*1/*3 and thyrotoxicosis.

J Korean Med Sci. 2014 Sep;29(9):1317-9. doi: 10.3346/jkms.2014.29.9.1317. Epub 2014 Sep 2.

Graves' disease and treatment effects on warfarin anticoagulation.

Case Rep Med. 2014;2014:292468. doi: 10.1155/2014/292468. Epub 2014 Jun 4.

A population-based assessment of the drug interaction between levothyroxine and warfarin.

Clin Pharmacol Ther. 2012 Dec;92(6):766-70. doi: 10.1038/clpt.2012.171. Epub 2012 Oct 24.

Potentiation of warfarin sodium by amiodarone-induced thyrotoxicosis.

West J Med. 1999 Jan;170(1):49-51.

Altered plasma protein binding of drugs in thyroid disease.

Clin Pharmacokinet. 1981 Jul-Aug;6(4):298-305. doi: 10.2165/00003088-198106040-00004.

Influence of thyroid dysfunction on drug pharmacokinetics.

Clin Pharmacokinet. 1981 Jul-Aug;6(4):275-97. doi: 10.2165/00003088-198106040-00003.

The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis.

Postgrad Med J. 1988 Oct;64(756):735-42. doi: 10.1136/pgmj.64.756.735.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验